| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$3,041,309 ) |
| | 2025 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | H4B37679 | Poison Control Stabilization and Enhancement Program | 01 | 6 | HRSA | 10/16/2024 | $0 |
| | 2025 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R01DK124185 | The Role of APE1/Ref-1 in Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Metaplasia: A Novel Target for Preventing Recurrent Barrett's Esophagus After Radiofrequency Ablation | 000 | 4 | NIH | 5/8/2025 | $0 |
| | 2025 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | CE152505 | Community Project Funding/Congressionally Directed Spending - Construction | 05 | 1 | HRSA | 12/4/2024 | -$3,000,000 |
| | 2025 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | CE152505 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 10/7/2024 | $0 |
| | 2025 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | CE152505 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 10/10/2024 | $0 |
| | 2025 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | H79TI085871 | Beta to Alpha | 000 | 1 | SAMHSA | 1/23/2025 | $0 |
| | 2025 | 2022 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R01AG061973 | GamePlan4Care: Web-based Delivery System for REACH II | 000 | 5 | NIH | 10/15/2024 | -$3,277 |
| | 2025 | 2022 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R01AG061973 | GamePlan4Care: Web-based Delivery System for REACH II | 000 | 5 | NIH | 10/15/2024 | -$5,282 |
| | 2025 | 2022 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | U01IP001189 | RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D). | 02 | 3 | CDC | 3/24/2025 | $0 |
| | 2025 | 2022 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0043 | Foundational Ingredients of Robotic Gait Training for People with Spinal Cord Injury During Inpatient Therapy (FIRST) | 03 | 1 | ACL | 4/11/2025 | $0 |
| | 2025 | 2021 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | G2943344 | Rural Health Clinic Vaccine Confidence Program | 06 | 1 | HRSA | 10/11/2024 | -$32,751 |
| | 2025 | 2021 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90DPTB0013 | North Texas Traumatic Brain Injury Model System | 02 | 5 | ACL | 10/10/2024 | $0 |
| | 2025 | 2021 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0043 | Foundational Ingredients of Robotic Gait Training for People with Spinal Cord Injury During Inpatient Therapy (FIRST) | 03 | 1 | ACL | 4/11/2025 | $0 |
| | 2025 | 2020 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0022 | Building an Evidence Base for Weight Loss Strategies among those with Chronic SCI | 04 | 3 | ACL | 10/28/2024 | $0 |
| | 2025 | 2020 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0021 | Efficacy Of An Evidence-Based Healthy Lifestyle Intervention For People Following CVA | 02 | 3 | ACL | 10/28/2024 | $0 |
| | 2025 | 2020 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90DPTB0013 | North Texas Traumatic Brain Injury Model System | 02 | 5 | ACL | 10/10/2024 | $0 |
| | 2025 | 2020 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0043 | Foundational Ingredients of Robotic Gait Training for People with Spinal Cord Injury During Inpatient Therapy (FIRST) | 03 | 1 | ACL | 4/11/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $4,530,916 ) (Continued on the next page) |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90DPTB0023 | North Texas Traumatic Brain Injury Model System | 01 | 3 | ACL | 8/6/2024 | $0 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0084 | Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino | 00 | 2 | ACL | 6/5/2024 | $200,000 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFDV0040 | Development of a telehealth platform for delivery of the Diabetes PreventionProgram Group Lifestyle Balance modified for people with TBI (GLB-TBI+) | 00 | 1 | ACL | 8/26/2024 | $200,000 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R21AG080339 | Driving Rehabilitation and Innovation for Evaluating Risk in Post-Intensive Care Unit Survivors (DRIVE-PICS) | 002 | 2 | NIH | 5/6/2024 | $236 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R21AG080339 | Driving Rehabilitation and Innovation for Evaluating Risk in Post-Intensive Care Unit Survivors (DRIVE-PICS) | 001 | 2 | NIH | 1/24/2024 | $236,337 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFDV0035 | Implementation of an Evidence-Based Educational Resource for Children with Mild Traumatic Brain Injury | 00 | 1 | ACL | 8/26/2024 | $200,000 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0074 | Early Robotic Gait Training After Stroke (ERA Stroke) | 00 | 2 | ACL | 6/5/2024 | $197,636 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R01DK131951 | Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett's Esophagus using TissueCypher: The SCRiBE study | 000 | 2 | NIH | 6/12/2024 | $545,202 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90SIMS0011 | Baylor Scott and White Spinal Cord Injury Model System | 00 | 4 | ACL | 7/22/2024 | $440,000 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90SIMS0011 | Baylor Scott and White Spinal Cord Injury Model System | 01 | 4 | ACL | 8/26/2024 | $30,000 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | U01IP001189 | RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D). | 00 | 3 | CDC | 7/5/2024 | $1,400,000 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | U01IP001189 | RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D). | 01 | 3 | CDC | 8/14/2024 | $0 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0088 | Expanding delivery of an evidence-based weight-loss intervention to enhance access and reach underserved groups after stroke | 00 | 1 | ACL | 7/15/2024 | $200,000 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R01OH012577 | Peer Delivered, Emotion Regulation-Focused Mental Health Prevention Training for Fire Fighter Trainees | 00 | 2 | CDC | 6/24/2024 | $569,558 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90DPTB0023 | North Texas Traumatic Brain Injury Model System | 00 | 3 | ACL | 7/12/2024 | $454,680 |
| | 2024 | 2024 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | H4B37679 | Poison Control Stabilization and Enhancement Program | 00 | 6 | HRSA | 8/21/2024 | $237,054 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0084 | Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino | 01 | 1 | ACL | 10/11/2023 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0084 | Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino | 00 | 2 | ACL | 6/5/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | H79TI085871 | Beta to Alpha | 002 | 1 | SAMHSA | 7/26/2024 | -$377,342 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | H79TI085871 | Beta to Alpha | 001 | 1 | SAMHSA | 4/17/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | H79TI085871 | Beta to Alpha | 000 | 1 | SAMHSA | 10/24/2023 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R21AG080339 | Driving Rehabilitation and Innovation for Evaluating Risk in Post-Intensive Care Unit Survivors (DRIVE-PICS) | 000 | 1 | NIH | 1/23/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0074 | Early Robotic Gait Training After Stroke (ERA Stroke) | 01 | 1 | ACL | 10/11/2023 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90IFRE0074 | Early Robotic Gait Training After Stroke (ERA Stroke) | 00 | 2 | ACL | 6/5/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90SIMS0011 | Baylor Scott and White Spinal Cord Injury Model System | 01 | 4 | ACL | 8/26/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | 90SIMS0011 | Baylor Scott and White Spinal Cord Injury Model System | 00 | 4 | ACL | 7/22/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | R21CA267885 | Salinomycin and its binding protein nucleolin in neuroblastoma | 000 | 2 | NIH | 6/11/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | U01IP001189 | RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D). | 00 | 3 | CDC | 7/5/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | U01IP001189 | RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D). | 01 | 3 | CDC | 8/14/2024 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | CE152505 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | BAYLOR RESEARCH INSTITUTE | 3434 LIVE OAK ST | DALLAS | TX | 75204-6134 | DALLAS | USA | CE152505 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
|
